Skip to main content
SpringerLink
Log in

Overdose toxicity studies versus threshold: elements of biology must be incorporated into risk assessment

  • Review
  • Regulation Aspects
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The estimation of risk and evaluation of risk/ benefit are traditionally and by necessity oriented at the current state of science and technology to ensure contemporary rights of safety. This demands a careful development in the methodology of hazard identification and risk assessment and its continuous updating and involvement. Compounds, e.g. erythrosine, 2,4,5-T, TCDD, and antioxidants, have still to be judged case-by-case, taking into account all available information on dosage, effect, kinetics, and mechanism of action, i. e., matters of biology rather than of mathematics alone. Considerations of mechanism of action and kinetics, especially recognition of low-dose/high-affinity assumptions in vitro, are necessary. This might lead to a new view upon thresholds which appears to apply for promoters. As accepted in pharmacology the dose-dependent magnitude of response observed in vivo is often a composite effect. Composite effects in toxicology can be viewed as having similar characteristics in vivo as in vitro in terms of potency, slope, maximal efficay and variability. Composite vectors can be antagonistic, leading to toxic and carcinogenic results, but also to protection. A continuous updating of scientific expertise supported by own experimental work is required for the regulator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Altmann HJ, Wester PW, Matthiaschk G, Grunow W, von der Heijden CA (1985) Induction of early lesions in forestomachs of rats by 3-tert-butyl-4-hydroxyanisole (BHA). Fd Chem Toxicol 23: 723–731

    Google Scholar 

  • Ames BN (1983) Dietary carcinogens and anticarcinogens, oxygen radicals and degenerative disease. Science 221: 1256–1264

    Google Scholar 

  • Appel KE, Hildebrandt AG (eds) (1985) Tumorpromotoren — Erkennung, Wirkungsmechanismen und Bedeutung. BGA-Schriften 6/85

  • Appel KE, Görsdorf S, Scheper T, Bauszus M, Hildebrandt AG (1986) Enzymatic denitrosation of diphenylnitrosamine: Activation or inactivation? Arch Toxicol 60: 204–208

    Google Scholar 

  • Brewer L, Jeffersen ND, Blair M, Thorstenson GB, Nair KPC, Richter WR, Keller WF, Goldenthal ET (1982) Long term dietary toxicity/carcinogenicity study in rats. Unpublished report from International Research and Development Cooperation Matterwaun Neb USA, submitted to WHO by CCMA

  • Bruce RD (1980) Low dose extrapolation and risk assessment. In: Chemical times and trends. Chemical Specialities Manufactures Association, pp 19–23

  • Chapman DE, Schiller CM (1985) Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Toxicol. Appl Pharmacol 78: 147–157

    Google Scholar 

  • Cohen GM, Bracken WM, Iyer RP, Berry DL, Selkirk JK, Slaga TJ (1979) Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p dioxin on benzo(a)pyrene and 7,12-dimethyl-benz(a)anthracene tumor initiation and its relationship to DNA binding. Cancer Res 39: 4027–4033

    Google Scholar 

  • Conney AH, Miller EC, Miller JA (1956) The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16: 450–459

    Google Scholar 

  • Couch RC, Hobsen WC, Selim S, Eason RL, Cumming LB, Cadwalader J, Helton ED (1983) Endocrine evaluation of thyroideal effects of FDC red 3. Unpublished report from the Primate Research Institute New Mexico State University, submitted to WHO by CCMA

  • Deichmann WB, MacDonald WE, Blum E (1970) Tumorigenicity of aldrin, dieldrin and endrin in the albino rat. Ind Med Surg 39: 426–434

    Google Scholar 

  • Efron E (1984) The apocalyptics. Simon and Schuster, New York.

    Google Scholar 

  • Goldstein AV, Aronow L, Kalman SM (1974) Consequences of drug-receptor interactions. In: AV Goldstein, L Aronow, SM Kalman (eds) Principles of Drug Action: The basis of pharmacology, John Wiley and Sons, Inc, New York, pp 82–111

    Google Scholar 

  • Goldsworthy Th, Campbell HA, Pitot HC (1984) The natural history and dose-response characteristics of enzyme altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis 5: 67–71

    Google Scholar 

  • Havender W (1986) Havender defends FDA decision. Food Chem News, p 27: 8

  • Hecker E (1985) Multifaktorielle und Mehrstufen-Karzinogenese — ätiologische (epidemiologische) und experimentelle Modelle sowie aktuelle Probleme der Bewertung von Krebsrisikofakten der Umwelt. In: Hildebrandt AG, Appel KE (eds) Tumorpromotoren — Erkennung, Wirkungsmechanismen und Bedeutung, BGA-Schriften 6: 14–42

  • Henschler D (1982) Die Bedeutung der Leber für die Biotransformation. AMI-Berichte, pp 68–73

  • Henschler D (1985) Carcinogenicity testing-existing protocolls are insufficient. TIPS FEST-Suppl, pp 26–28

  • Hildebrandt AG, Lewandowski G, Lucas K (1984) Background and current Status of safety assessment of food and food chemicals in the Federal Republic of Germany. Proceedings of the ILSI International Symposium on Safety Assessment. Tokyo, Japan, pp 38–45

  • Hill AV (1913) XLVII. The combinations of haemoglobin with oxygen and with carbon monoxide. J Biochem J 7: 417

    Google Scholar 

  • Hoel DG, Kaplan NL, Marshall W, Anderson (1983) Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science 219: 1032–1037

    Google Scholar 

  • Imaida K, Fukushima S, Shirai T, Otani M, Nakanishi K, Ito N (1983) Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of γ-glutamyl-transpeptidase positive foci development in the liver of rats. Carcinogenesis 4: 895–899

    Google Scholar 

  • Ito N, Fukushima S, Hagiwara A, Shibata M, Ogiso T (1983) Carcinogenicity of butylated hydroxyanisole in F344 rats. J Natl Cancer Inst 70: 343–352

    Google Scholar 

  • Kahl R, Weimann A, Weinke S, Hildebrandt AG (1987) Detection of oxygen activation and determination of the activity of antioxidants towards reactive oxygen species by use of the chemiluminigenic probes luminol and lucigenin. Arch Toxicol 60: 158–162

    Google Scholar 

  • Kensler TW, Egner PA, Thrush MA, Bueding E, Gropman JD (1985) Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and dithiolthione. Carcinogenesis 6: 759–763

    Google Scholar 

  • Kimbrough RD, Falk H, Stehr P, Fries G (1984) Health implication of 2,3,7,8-tetrachlorodibenzodioxin (TCDD) contamination of residential soil. J Toxicol Environ Health 14: 47–93

    Google Scholar 

  • Koshiba RJ, Klyes DG, Beyer JE, Carreon RM, Wade EE, Diltenber DA, Kalnins RP, Frauson LF, Park DN, Barnard SD, Hummel RA, Humiston CG (1978) Results of a two year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol Appl Pharmacol 46: 279–303

    Google Scholar 

  • Liébecq CI (1971) Introduction to enzyme kinetics. In: Bacq ZM, Capek R, Paoletti R, Renson J (eds) Fundamentals of biochemical pharmacology. Pergamon Press Oxford, pp 59–86

    Google Scholar 

  • National Toxicology Program (NTP) Carcinogenesis bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin (CAS No 1746-01-6) in Osborne-Mendel rats and B6C3-F1 Mice (gavage study). NTP Technical Report Series 209: 195

  • OECD Guidelines for Testing of Chemicals; Carcinogenicity Studies (1981) Number 451. Publication Office, 2, Rue Andrè- Pascal, Paris, France

  • Olson P, Meyer O, Bille N, Würtzen G (1986) Carcinogenicity study on butylated hydroxytoluene (BHT) in Wistar rats exposed in utero. Fd Chem Toxicol 24: 1–12

    Google Scholar 

  • Poland A, Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Ann Rev Pharmacol Toxicol 22: 517–554

    Google Scholar 

  • Sakata T, Shirai T, Fukushima S, Hasegawa R, Ito N (1984) Summation and synergism in the promotion of urinary bladder Carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats. Gann 75: 950–956

    Google Scholar 

  • Sauerhoft MW, Braun WH, Blau GF, Gehring PJ (1976) The dose-dependent pharmacokinetic profile of 2,4,5-trichlorophenoxyacetic acid following intravenous administration to rats. Toxicol Appl Pharmacol 36: 491–501

    Google Scholar 

  • Scarlett Th (1986) Food Chemical News 27: 4–6

    Google Scholar 

  • Stephenson RP, Barlow RB (1970) Concepts of drug action, quantitative pharmacology and biological assay. In: Passmore R, Robson JS (eds) A companion to medical studies, Philadelphia, Blackwell Scientific Publ Ltd FA Davis, Co: Chapter 3

    Google Scholar 

  • Stohs SJ, Hassan MQ, Murray WJ (1984) Effects of BHA, a-tocopherol and retinol acetate on TCDD mediated changes in lipid peroxidation, glutathione peroxidase activity and survival. Xenobiotica 14: 533–537

    Google Scholar 

  • Strauss OH, Goldstein AV (1943) Zone behavior of enzymes. J Gen Physiol 26: 559

    Google Scholar 

  • Wattenberg LW (1980) Inhibitors of chemical carcinogenesis. J Environ Pathol Toxicol 3: 35–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Max von Pettenkofer Institut des Bundesgesundheitsamtes, Thielallee 88-92, D-1000, Berlin 33

    Alfred G. Hildebrandt

Authors
  1. Alfred G. Hildebrandt
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Professor Dr. med. Herbert Remmer on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hildebrandt, A.G. Overdose toxicity studies versus threshold: elements of biology must be incorporated into risk assessment. Arch Toxicol 60, 217–223 (1987). https://doi.org/10.1007/BF00296984

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296984

Key words

Search

Navigation